Molecular imaging 'probes' pinpoint prostate cancer
Molecular imaging has a powerful new weapon in the fight against prostate cancer. Research introduced at SNM's 57th Annual Meeting demonstrates how a novel peptide-targeted imaging agent could help clinicians detect a biological process that signals cancer in prostate cells. Information gathered about this process may even differentiate prostate tumor types and the progression of disease. "This new molecular imaging tool will help us develop new diagnostic and therapeutic options for prostate cancer patients," said Chiun-Wei Huang, Ph.D. candidate, lead author and researcher at the Molecular Imaging Center of the Keck School of Medicine, University of Southern California, Los Angeles, Calif. "By identifying a signature on the cell-surface of specific tumor types at different stages, we could potentially develop better and more customized treatments for truly personalized medicine."
In this study, researchers used near-infrared fluorescent imaging, an optical imaging technique that images the low-frequency light emitted from an imaging agent containing fluorescent dye. The novel agent used in the study was prepared with a peptide that targets receptor activity involved in the prolific growth of certain tumor cells. This specific sequence of receptor activity is called α2β1 integrin, an expression of building-block proteins such as collagen. Cells that display an abnormal over-abundance of this activity could be cancerous, and imaging that focuses on this biological process could provide essential information about the aggressive growth, survival, migration and invasiveness of individual cases of prostate cancer.
Results of the study showed that high absorption of the peptide-targeted agent positively identified prostate tumors both in the laboratory and in three prostate tumor-bearing models. Further development of this and similar imaging agents could lead to more effective and detailed diagnosis of prostate cancer and could be used to test the effectiveness of new drug therapies to treat the disease.
Source: Society of Nuclear Medicine
Articles on the same topic
- Radioactive optical imaging and 'quantum dot' nano-imaging at the forefront of molecular medicineMon, 7 Jun 2010, 22:05:45 UTC
- Molecular imaging can improve effectiveness of novel therapy for advanced heart diseaseMon, 7 Jun 2010, 18:15:18 UTC
- Feet first: Molecular imaging helps diagnose diabetic foot infectionMon, 7 Jun 2010, 18:15:16 UTC
- Molecular imaging prototype looks deep into soft tissues of the brain and other organsMon, 7 Jun 2010, 18:15:14 UTC
- Molecular imaging agent coupled with 'motion frozen' processing improves heart imagingMon, 7 Jun 2010, 18:15:13 UTC
- Molecular imaging allows individualized 'dose painting' for head and neck cancersMon, 7 Jun 2010, 18:15:02 UTC
- Molecular imaging helps predict breast cancer survivalMon, 7 Jun 2010, 18:14:55 UTC
- Targeted radioisotope generator could be used for molecular imagingMon, 7 Jun 2010, 18:14:53 UTC
- Molecular imaging may be best for capturing renal transplant complicationsMon, 7 Jun 2010, 18:14:51 UTC
- Blood-sugar lowering medications may increase risk for false positive results in cancer screeningsMon, 7 Jun 2010, 18:14:50 UTC
- Molecular imaging detects recurrent prostate cancerMon, 7 Jun 2010, 4:25:24 UTC
Other sources
- Molecular imaging can improve effectiveness of novel therapy for advanced heart diseasefrom PhysorgTue, 8 Jun 2010, 3:10:47 UTC
- Molecular imaging agent coupled with 'motion frozen' processing improves heart imagingfrom PhysorgMon, 7 Jun 2010, 21:52:26 UTC
- Radioactive optical imaging and 'quantum dot' nano-imaging at the forefront of molecular medicinefrom PhysorgMon, 7 Jun 2010, 21:51:57 UTC
- Molecular imaging detects recurrent prostate cancerfrom Biology News NetMon, 7 Jun 2010, 21:10:53 UTC
- Molecular imaging 'probes' pinpoint prostate cancerfrom PhysorgMon, 7 Jun 2010, 20:43:45 UTC
- Feet first: Molecular imaging helps diagnose diabetic foot infectionfrom PhysorgMon, 7 Jun 2010, 20:43:23 UTC
- Targeted radioisotope generator could be used for molecular imagingfrom PhysorgMon, 7 Jun 2010, 17:31:46 UTC
- Blood-sugar lowering medications may increase risk for false positive results in cancer screeningsfrom PhysorgMon, 7 Jun 2010, 17:31:34 UTC
- New molecular imaging agent may help visualize early stages of Alzheimer's diseasefrom PhysorgMon, 7 Jun 2010, 17:31:32 UTC
- Molecular imaging helps predict breast cancer survivalfrom PhysorgMon, 7 Jun 2010, 17:31:31 UTC
- Molecular imaging may be best for capturing renal transplant complicationsfrom PhysorgMon, 7 Jun 2010, 17:31:23 UTC
- Molecular imaging detects recurrent prostate cancerfrom PhysorgMon, 7 Jun 2010, 4:20:51 UTC